4CPS-117 Relationship between daily dose frequency and adherence in chronic myeloid leukaemia

BACKGROUND: Adherence to tyrosine-kinase inhibitors (TKIs) treatment is regarded as one of the mainstays of chronic myeloid leukaemia (CML). PURPOSE: To analyse the variability in the adherence to TKIs treatment of CML in the function of the prescribed drug and evaluate how pharmaceutical care can i...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Eur J Hosp Pharm
Autors principals: Gil, S García, Casariego, GJ Nazco, Romero, MM Viña, Virginia, G, Alarcón, C, Piñero, M, García, J González, Nicolás, F Gutiérrez
Format: Artigo
Idioma:Inglês
Publicat: BMJ Group 2018
Matèries:
Section 4: Clinical pharmacy services
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535459/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.208
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars